Publications 2015


PUBLICATIONS:
1. Carmustine, etoposide, cytarabine, and melphalan (BEAM)-campath allogeneic stem cell transplantation for aggressive non-hodgkin lymphoma: an analysis of outcomes from the British Society of Blood and Marrow Transplantation. Truelove E, Fox C, Robinson S, Pearce R, Perry J, Kirkland K, McQuaker G, Pagliuca A, Johnson P, Russell N, Cook G.
British Society for Blood and Marrow Transplantation (BSBMT). Biol Blood Marrow Transplant. 2015 Mar;21(3):483-8.

2. Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: a British Society of Blood and Marrow Transplantation study.Nikolousis E, Nagra S, Pearce R, Perry J, Kirkland K, Byrne J, Dignan F, Tholouli E, Gilleece M, Russell N, Littlewood T, Cook M, Peniket A, Shaw BE, Cook G, Craddock C.
Bone Marrow Transplant. 2015 Jan;50(1):82-6.

3. Autologous Stem Cell Transplantation Is an Effective Salvage Therapy for Primary Refractory Multiple Myeloma. Parrish C, Rahemtulla A, Cavet J, Pearce RM, Kirkland K, Lee J, Cook M, Wilson K, Cook G; Clinical Trials Committee of the British Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2015 Jul;21(7):1330-4.

ABSTRACTS:
1. Provision of Long-term Monitoring and Late Effects Services Following Allogeneic HSCT in Adults: A British Society of Blood and Marrow Transplantation (BSBMT) Survey of UK NHS-Based Programmes.A. Hamblin, D. Greenfield, M. Gilleece, N. Salooja, M. Kenyon, E. Morris, N. Glover, P. Miller, H. Braund, A. Peniket, B. Shaw, J. A. Snowden on behalf of BSBMT Clinical Trials Committee Oral presentation158 EBMT Istanbul 2015